New combination therapy safe, promising for melanoma patients

Jun 01, 2008

The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Researchers in the melanoma and skin cancer program at UPCI combined two biotherapies – treatments that stimulate the immune system to fight cancer – and found the results promising in terms of anti-tumor effects and tolerable in terms of toxicity. High-dose interferon alfa-2b, a standard treatment for metastatic skin cancer, and tremelimumab, an antibody thought to instigate the body’s immune system to attack tumors, were combined for the first time in this phase 2 clinical trial.

“With each new study, we learn something important about melanoma,” said John M. Kirkwood, M.D., leader of the program and professor and vice chairman for clinical research in the Department of Medicine, University of Pittsburgh School of Medicine. “With this study, we learned that adding tremelimumab to traditional treatment is not only safe, but an effective way to induce an anti-tumor response, which is very exciting.”

For this study, 16 patients diagnosed with stage 4 melanoma, all of whom received and had not benefited from at least one round of previous therapy, were given the combination treatment. The overall response rate was 19 percent, and the study has since moved into the second stage, where it will enroll 21 additional patients.

Melanoma is a rare form of skin cancer, but it causes the majority of skin cancer-related deaths. Each year, approximately 160,000 new cases are diagnosed worldwide, and currently surgery is the only effective cure. For patients with inoperable disease, like those enrolled in this study, discovering a safe and effective treatment is vital.

Source: University of Pittsburgh

Explore further: New survey shows 36-percent increase in pediatric patients treated with proton therapy

Related Stories

Salt-tolerant herb rich in antioxidant compounds

May 19, 2015

Epidemiological studies have emphasised the importance of eating foods high in antioxidants to reduce the risk of developing cancer and cardiovascular disease, two leading causes of death worldwide. Inside ...

Topology looks for the patterns inside big data

May 18, 2015

Big data gets much attention from media, industry and government. Companies and labs generate massive amounts of data associated with everything from weather to cell phone usage to medical records, and each data set may involve hundreds of variables. ...

Organic nanoparticles, more lethal to tumours

May 18, 2015

Radiotherapy used in cancer treatment is a promising treatment method, albeit rather indiscriminate. Indeed, it affects neighbouring healthy tissues and tumours alike. Researchers have thus been exploring the possibilities ...

Recommended for you

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jun 01, 2008
Nearly all "cancers" result from accelerated mitosis, which involves ENERGY, (ie high-speed electrons). "Freezing" kills any cell, (robbing it of energy). "Cooling", (decreasing electron speed & energy), slows mitosis, arrests cancer!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.